# Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

> **NCT05480878** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 90 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Placebo
- **DRUG:** Nitazoxanide 500Mg Oral Tablet
- **DRUG:** Escitalopram 10mg

## Key facts

- **NCT ID:** NCT05480878
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-02
- **Primary completion:** 2023-03-25
- **Final completion:** 2023-04-01
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05480878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05480878, "Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05480878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*